SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Atossa Therapeutics, Inc. ATOS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Atossa Therapeutics, Inc. (ATOS) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 AVRO, CWBR, ELEV, ENVB, GOVX, IBIO 等.

ATOS 的市值为 $49.43M, 而同行平均市值为 $183.74M. ATOS 显著小于其平均同行.

同行与相似公司 — ATOS

$1.40 -1.41% $5.24M

$0.41 0.00% $1.19M

Elevation Oncology, Inc.

$0.37 -2.12% $21.63M

Enveric Biosciences, Inc.

$2.03 +4.10% $1.21M

GeoVax Labs, Inc.

$1.28 -4.48% $1.3M

$2.10 -4.11% $33.16M

Inovio Pharmaceuticals, Inc.

$1.19 +7.21% $63.77M

Jaguar Health, Inc.

$0.42 +4.19% $986.66K

$8.69 +3.58% $1.42B

Ocean Biomedical, Inc.

$1.95 +8.33% $639.4M

Onconova Therapeutics, Inc.

$1.00 -0.47% $20.9M

其他人也在看

Palisade Bio, Inc.

Tonix Pharmaceuticals Holding Corp.

Inovio Pharmaceuticals, Inc.

Elevation Oncology, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言